Blood Glucose Monitoring Devices Market

Blood Glucose Monitoring Devices Market Overview

The blood glucose monitoring devices market size, valued at USD 24.2 billion in 2025, is projected to reach USD 26.5 billion in 2026 and USD 34 billion by 2030, with a CAGR of 6.3% during the forecast period 2026 to 2030.

To learn more about this report, request a free sample copy

Timely glucose monitoring helps prevent unwanted glucose fluctuations (hyperglycemia / hypoglycemia), which are known to have serious implications, including (but not limited to) kidney damage, cardiovascular complications, visual impairment, diabetic ketoacidosis and circulatory defects (some of which are known to progress to a stage requiring amputation). The current gold standard for self-monitoring of blood glucose level involves the use glucose meters. These are compact devices designed to measure glucose levels in blood, which is typically extracted (using a small needle) from patients’ fingertips or forearms. For adequate glycemic control, it is essential for diabetics to measure glucose levels multiple (3-4) times in a day; since the process involves the use of a needle, compliance is a primary concern. Moreover, there are several other concerns, such as inaccurate readings and needlestick injuries, associated with the use of conventional glucose monitoring devices.

Blood Glucose Monitoring Devices Market Drivers

Diabetes is one of the seven leading causes of death and disability across the world. According to the World Health Organization (WHO), more than 1.6 million deaths are directly attributed to diabetes each year. In 2019, the global expenditure on diabetes treatment and disease management was estimated to be over USD 750 billion; this is indicative of the significant burden on patients and the global healthcare system.

The blood glucose monitoring devices market is anticipated to witness steady market growth, largely driven by the increasing diabetic patient population and the introduction of advanced and cost effective solutions, during the forecast period.

Technological Advancements in Blood Glucose Monitoring Devices Market

Over time, a number of companies have developed advanced variants of the conventional blood glucose monitors that are portable, and minimally- / non-invasive. Many such next generation solutions have connectivity features, which enable patients’ health data to be captured and shared with medical professionals, upon request.

In addition, there are a number of innovative continuous glucose monitoring (CGM) systems, which are designed to provide real-time insights on blood glucose levels. In March 2024, the USFDA approved Dexcom's Stelo Glucose Biosensor System, an over-the-counter continuous glucose monitoring device for anyone 18 years and older, who does not use insulin. Newer variants of these products are now chockful of intuitive software that enables patients to quickly make important treatment-related decisions. This field is presently the epicenter of innovation in the diabetes market; a popular example is the artificial pancreas, which is basically a combination of a CGM system and a wearable injectors, powered by intuitive algorithms that drive the delivery of insulin and glucagon.

Key Companies in Blood Glucose Monitoring Devices Market 

Examples of key companies engaged in developing blood glucose meters (which have also been profiled in this market report; the complete list of companies is available in the full report) include ApexBio, Ascensia Diabetes Care, i-SENS, Oak Tree Health, SD Biosensor, TaiDoc Technology and VivaCheck Laboratories. This market report includes an easily searchable excel database of all the companies providing blood glucose meters, worldwide.

Recent Developments in Diabetes Monitoring Devices Market

Several recent developments have taken place in the field of blood glucose monitoring devices. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.

• In March 2026, Glucotrack announced plans to file an Investigational Device Exemption for its continuous blood glucose monitor implant.
• In March 2026, Glucotrack reported progress on its 3-year implantable CBGM device, planning FDA IDE submission.

Scope of the Diabetes Monitoring Devices Market Report

The “Blood Glucose Monitoring Devices Market, till 2030” market report features an extensive study of the current market landscape, market size, market share, market forecast, market outlook and future opportunities of the blood glucose monitoring devices market. The market research report also features a detailed analysis of the key drivers and trends related to blood glucose monitoring devices industry.

Amongst other elements, the market research report includes:

• An overview of current market landscape of the diabetes monitoring devices, providing information on device specifications, such as type of device (self-monitoring blood glucose device and continuous blood glucose monitoring devices), current status of development (preclinical, clinical and marketed), target patient segment (children, adults and elderly patients), analyte procurement (invasive, non-invasive and minimally invasive), volume of analyte used (less than 0.8 µL, 0.8 to 2 µL and more than 2 µL), processing speed (fast and slow), wearability (wearable and non-wearable), wireless connectivity, water resistance potential, provision for alerts / alarms, device memory attributes and glucose measurement range. In addition, the report presents the details of the companies developing these devices, including information on type of developer (industry and non-industry), year of establishment, company size, location of headquarters and leading developers. 
• A detailed competitiveness analysis of diabetes monitoring devices, taking into consideration the supplier power (based on the experience / expertise of the developer) and product specifications (type of device, current status of development, target patient segment,  analyte procurement, volume of analyte used, processing speed, wireless connectivity, water resistance potential, provision for alerts / alarms and device memory attributes).
• An analysis of the partnerships that have been inked by the stakeholders in blood glucose monitoring devices market, during the period between 2015 and 2020 (till August), covering product / technology integration agreements, commercialization agreements, distribution agreements, product development agreements, acquisitions, product development and commercialization agreements and other relevant types of deals.
• Elaborate profiles of prominent companies that develop diabetes monitoring devices. Each company profile features a brief overview of the company, its financial information (if available), information on its product portfolio, recent developments and an informed future outlook. 
• A review of recent initiatives undertaken by big pharma players in blood glucose monitoring devices market. It also features a benchmark analysis of top 5 big pharma players (in terms of annual revenues of 2019), comparing them across various relevant parameters.

The key objective of blood glucose monitoring devices market report is to provide a detailed market analysis in order to estimate the existing market size, market value, statistics and future opportunity for blood glucose monitoring systems during the forecast period. Based on multiple parameters, such as the number of commercialized devices, number of devices under development, price of the device and the annual adoption rate, we have provided an informed estimate on the likely evolution of the market over the forecast period till 2030. The market report also features sales forecasts for the overall blood glucose monitoring devices market with a detailed market segmentation on the [A] type of device (self-monitoring blood glucose device and continuous blood glucose monitoring device), [B] diabetes type (type 1 diabetes and type 2 diabetes), [C] device component (self-monitoring blood glucose devices: lancing device, blood glucose meter and testing strips; continuous glucose monitoring devices: sensors, transmitter and receiver) and [D] key geographical regions (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa and rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios namely the conservative, base and optimistic scenarios, which represent different tracks of the industry’s evolution.

Frequently Asked Questions

Question 1: What are blood glucose monitoring devices?

Answer: Blood glucose monitoring devices are a class of devices which can be used by patients to keep a check on their blood glucose levels.

Question 2: How big is the blood glucose monitoring devices market?

Answer: The blood glucose monitoring systems market size is estimated to be worth $16 billion in 2020.

Question 3: What is the projected market growth of the blood glucose monitoring devices market?

Answer: The blood glucose monitoring devices market is expected to grow at compounded annual growth rate (CAGR) of 8% during the forecast period 2020 – 2030.

Question 4: Who are the leading blood glucose meter developers in the blood glucose monitoring devices market?

Answer: Examples of key companies engaged in blood glucose monitoring systems market (which have also been profiled in this market report; the complete list of companies is available in the full report) include ApexBio, Ascensia Diabetes Care, i-SENS, Oak Tree Health, SD Biosensor, TaiDoc Technology and VivaCheck Laboratories.

Question 5: What is the global expenditure on diabetes treatment disease management?

Answer: In 2019, the global expenditure on diabetes treatment and disease management was estimated to be over USD 750 billion.

Question 6: How many blood glucose meters are presently marketed by companies engaged in the blood glucose monitoring devices market?

Answer: Presently, over 240 blood glucose meters are marketed by companies engaged in the blood glucose monitoring devices market.

Question 7: How many partnerships have been inked between the companies engaged in blood glucose monitoring devices market?

Answer: Since 2015, more than 70 partnerships have been inked between the players engaged in blood glucose monitoring systems market, indicating the consolidation efforts of stakeholders in the industry.